Pill Identifier App

Vetera EWT (Canada)

This page contains information on Vetera EWT for veterinary use.
The information provided typically includes the following:
  • Vetera EWT Indications
  • Warnings and cautions for Vetera EWT
  • Direction and dosage information for Vetera EWT

Vetera EWT

This treatment applies to the following species:
Manufacturer: Boehringer

Encephalomyelitis Vaccine

Eastern & Western, Killed Virus

Tetanus Toxoid

Veterinary Use Only

Vetera EWT Indications

For vaccination of healthy horses 4 months of age or older as an aid in the prevention of disease caused by Eastern and Western Encephalomyelitis and tetanus.

Administration and Dosage: Shake well before use. Using aseptic technique, vaccinate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure with a single 1 mL intramuscular dose.


Store at 2-7°C. Do not freeze. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur following use. Antidote: Epinephrine. Preservatives: Gentamicin and Amphotericin B.

Vetera® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH.

Manufactured by: Boehringer Ingelheim Vetmedica, Inc., St. Joseph, Missouri 64506 U.S.A.

U.S. Vet. Lic. No. 124

Manufactured for: Boehringer Ingelheim (Canada) Ltd., Burlington, Ontario L7L 5H4

1 Dose/1 mL


NAC No.: 12301280

Customer Care No.:   800-567-1885
Technical Services No.:   1-877-565-5501
Website:   www.boehringer-ingelheim.ca
Every effort has been made to ensure the accuracy of the Vetera EWT information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2015 North American Compendiums. Updated: 2014-12-03